Abstract
M/emm typing, based either on serotyping of the M protein or on sequencing of the emm gene, is a major tool for epidemiological studies of group A streptococci (GAS). In order to simplify M/emm typing, we designed two multiplex polymerase chain reaction (PCR) formats capable of identifying the most frequent GAS M/emm types involved in invasive infections and antimicrobial resistance. A heptaplex PCR procedure was first developed in a conventional format coupled with gel electrophoresis to identify emm types 1, 3, 4, 6, 12, 28, and 89, based on the size of the amplification products. The other method, designed to identify the same seven emm types, together with emm11, was based on a real-time PCR format coupled with high-resolution melting (HRM) analysis, allowing the rapid typing of large strain collections.
Similar content being viewed by others
References
Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470–511
Efstratiou A (2000) Group A streptococci in the 1990s. J Antimicrob Chemother 45(Suppl):3–12
Bingen E, Bidet P, Mihaila-Amrouche L, Doit C, Forcet S, Brahimi N, Bouvet A, Cohen R (2004) Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother 48(9):3559–3562
Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstratiou A, Hallas G, Seppälä H (1998) Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 177(3):786–789
Katz KC, McGeer AJ, Duncan CL, Ashi-Sulaiman A, Willey BM, Sarabia A, McCann J, Pong-Porter S, Rzayev Y, de Azavedo JS, Low DE (2003) Emergence of macrolide resistance in throat culture isolates of group A streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother 47(7):2370–2372
Syrogiannopoulos GA, Grivea IN, Fitoussi F, Doit C, Katopodis GD, Bingen E, Beratis NG (2001) High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr Infect Dis J 20(9):863–868
Tamayo J, Pérez-Trallero E, Gómez-Garcés JL, Alós JI; Spanish Group for the Study of Infection in the Primary Health Care Setting (2005) Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J Antimicrob Chemother 56(4):780–782
Bidet P, Courroux C, Salgueiro C, Carol A, Mariani-Kurkdjian P, Bonacorsi S, Bingen E (2007) Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children. J Clin Microbiol 45(6):2002–2004
Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B; Strep-EURO Study Group, Jasir A (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47:1155–1165
Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR (1995) Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 63(3):994–1003
O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A (2002) Epidemiology of invasive group a streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35(3):268–276
O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C; Active Bacterial Core Surveillance Team (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 45(7):853–862
Vlaminckx B, van Pelt W, Schouls L, van Silfhout A, Elzenaar C, Mascini E, Verhoef J, Schellekens J (2004) Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992–1996. Eur J Clin Microbiol Infect Dis 23(6):434–444
Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA (2005) Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis 191(8):1272–1279
Reinert RR, Lütticken R, Bryskier A, Al-Lahham A (2003) Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000–2001. Antimicrob Agents Chemother 47(2):489–493
Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis 41(5):599–608
Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB (2002) Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 70(4):2171–2177
McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB (2005) Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41(8):1114–1122
Olive C (2007) Progress in M-protein-based subunit vaccines to prevent rheumatic fever and rheumatic heart disease. Curr Opin Mol Ther 9(1):25–34
Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, Thompson TA, Gowan S, Kriz P, Tyrrell GJ, Kaplan E, Beall B (2002) Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 34(1):28–38
Lancefield RC (1940) Type-specific antigens, M and T, of matt and glossy variants of group A hemolytic streptococci. J Exp Med 71(4):521–537
Swift HF, Wilson AT, Lancefield RC (1943) Typing group A hemolytic streptococci by M precipitin reactions in capillary pipettes. J Exp Med 78(2):127–133
Beall B, Facklam R, Thompson T (1996) Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953–958
Guillemot D, Weber P, Bidet P, Cohen R, Péan Y, Choutet P, Poyart C, Bernède C, Bingen E, Portier H (2007) Sensibilité aux macrolides et apparentés de Streptococcus pyogenes (SGA) au cours des angines aiguës en France, hiver 2005–2006. Bull Épidémiol Hebd 33:291–293
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673–4680
Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49(6 Pt 1):853–860
Erali M, Voelkerding KV, Wittwer CT (2008) High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 85(1):50–58
Vitali LA, Zampaloni C, Prenna M, Ripa S (2002) PCR m typing: a new method for rapid typing of group A streptococci. J Clin Microbiol 40(2):679–681
Saunders NA, Hallas G, Gaworzewska ET, Metherell L, Efstratiou A, Hookey JV, George RC (1997) PCR-enzyme-linked immunosorbent assay and sequencing as an alternative to serology for M-antigen typing of Streptococcus pyogenes. J Clin Microbiol 35(10):2689–2691
Acknowledgment
We thank Prof. Anne Bouvet for her critical review of the manuscript and helpful discussions.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bidet, P., Liguori, S., Plainvert, C. et al. Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis. Eur J Clin Microbiol Infect Dis 31, 2817–2826 (2012). https://doi.org/10.1007/s10096-012-1635-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1635-5